Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study

BACKGROUND: Inhaled nitric oxide (iNO) is used as rescue therapy in patients with refractory hypoxemia due to severe COVID-19 acute respiratory distress syndrome (ARDS) despite the recommendation against the use of this treatment. To date, the effect of iNO on the clinical outcomes of critically ill...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Korayem, Ghazwa B., Altebainawi, Ali F., Al Harbi, Shmeylan, Alissa, Abdulrahman, Alharthi, Abdullah, Kensara, Raed, Alfahed, Amjaad, Vishwakarma, Ramesh, Al Haji, Hussain, Almohaimid, Naif, Al Zumai, Omar, Alrubayan, Fahad, Asiri, Abdulmajid, Alkahtani, Nasser, Alolayan, Abdulaziz, Alsohimi, Samiah, Melibari, Nawal, Almagthali, Alaa, Aljahdali, Seba, Alenazi, Abeer A., Alsaeedi, Alawi S., Al Ghamdi, Ghassan, Al Faris, Omar, Alqahtani, Joud, Al Qahtani, Jalal, Alshammari, Khalid A., Alshammari, Khalil I., Aljuhani, Ohoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527729/
https://www.ncbi.nlm.nih.gov/pubmed/36192801
http://dx.doi.org/10.1186/s13054-022-04158-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527729/
https://www.ncbi.nlm.nih.gov/pubmed/36192801
http://dx.doi.org/10.1186/s13054-022-04158-y

Ejemplares similares